Sugar-Lowering Drugs for Type 2 Diabetes Mellitus and Metabolic Syndrome—Strategies for In Vivo Administration: Part-II

Diabetes is a complex disease characterized by hyperglycemia, together with polyuria, polydipsia, and polyphagia. While Type 1 diabetes mellitus (T1DM) results from genetic, environmental, or immune dysfunction factors leading to pancreatic β-cell destruction depriving the organism from endogenous i...

Descripción completa

Detalles Bibliográficos
Autores principales: Vieira, Raquel, Souto, Selma B., Sánchez-López, Elena, López Machado, Ana, Severino, Patricia, Jose, Sajan, Santini, Antonello, Silva, Amelia M., Fortuna, Ana, García, Maria Luisa, Souto, Eliana B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6780268/
https://www.ncbi.nlm.nih.gov/pubmed/31466386
http://dx.doi.org/10.3390/jcm8091332

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6780268/
https://www.ncbi.nlm.nih.gov/pubmed/31466386
http://dx.doi.org/10.3390/jcm8091332

Ejemplares similares